Globus Medical, Inc. (BMV:GMED)

Globus Medical Statistics

Total Valuation

Globus Medical has a market cap or net worth of MXN 221.84 billion. The enterprise value is 216.61 billion.

Market Cap	221.84B
Enterprise Value	216.61B

Important Dates

The next estimated earnings date is Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	111.41M
Shares Outstanding	n/a
Shares Change (YoY)	+1.31%
Shares Change (QoQ)	-0.81%
Owned by Insiders (%)	17.22%
Owned by Institutions (%)	90.22%
Float	110.51M

Valuation Ratios

The trailing PE ratio is 28.54 and the forward PE ratio is 22.07.

PE Ratio	28.54
Forward PE	22.07
PS Ratio	4.37
PB Ratio	2.75
P/TBV Ratio	5.52
P/FCF Ratio	20.87
P/OCF Ratio	16.91
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.49, with an EV/FCF ratio of 20.38.

EV / Earnings	27.87
EV / Sales	4.30
EV / EBITDA	14.49
EV / EBIT	22.72
EV / FCF	20.38

Financial Position

The company has a current ratio of 4.13, with a Debt / Equity ratio of 0.03.

Current Ratio	4.13
Quick Ratio	2.31
Debt / Equity	0.03
Debt / EBITDA	0.15
Debt / FCF	0.21
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 10.01% and return on invested capital (ROIC) is 7.18%.

Return on Equity (ROE)	10.01%
Return on Assets (ROA)	6.43%
Return on Invested Capital (ROIC)	7.18%
Return on Capital Employed (ROCE)	11.32%
Revenue Per Employee	9.59M
Profits Per Employee	1.47M
Employee Count	5,300
Asset Turnover	0.54
Inventory Turnover	1.21

Taxes

In the past 12 months, Globus Medical has paid 673.58 million in taxes.

Income Tax	673.58M
Effective Tax Rate	7.97%

Stock Price Statistics

The stock price has increased by +24.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+24.53%
50-Day Moving Average	1,365.91
200-Day Moving Average	n/a
Relative Strength Index (RSI)	62.12
Average Volume (20 Days)	555

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.85

Income Statement

In the last 12 months, Globus Medical had revenue of MXN 50.80 billion and earned 7.77 billion in profits. Earnings per share was 56.48.

Revenue	50.80B
Gross Profit	34.30B
Operating Income	9.61B
Pretax Income	8.45B
Net Income	7.77B
EBITDA	14.67B
EBIT	9.61B
Earnings Per Share (EPS)	56.48

Balance Sheet

The company has 7.16 billion in cash and 2.20 billion in debt, giving a net cash position of 5.27 billion.

Cash & Cash Equivalents	7.16B
Total Debt	2.20B
Net Cash	5.27B
Net Cash Per Share	n/a
Equity (Book Value)	80.68B
Book Value Per Share	599.41
Working Capital	26.75B

Cash Flow

In the last 12 months, operating cash flow was 13.12 billion and capital expenditures -2.49 billion, giving a free cash flow of 10.63 billion.

Operating Cash Flow	13.12B
Capital Expenditures	-2.49B
Free Cash Flow	10.63B
FCF Per Share	n/a

Margins

Gross margin is 67.51%, with operating and profit margins of 18.92% and 15.30%.

Gross Margin	67.51%
Operating Margin	18.92%
Pretax Margin	16.63%
Profit Margin	15.30%
EBITDA Margin	28.87%
EBIT Margin	18.92%
FCF Margin	20.93%

Dividends & Yields

Globus Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.31%
Shareholder Yield	-1.31%
Earnings Yield	3.50%
FCF Yield	4.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Globus Medical has an Altman Z-Score of 9.87 and a Piotroski F-Score of 7.

Altman Z-Score	9.87
Piotroski F-Score	7